Exercise and diet for people with hip osteoarthritis: the ECHO feasibility study

Not Applicable

Completed

• Conditions: Hip osteoarthritis; Obesity; Musculoskeletal - Osteoarthritis; Diet and Nutrition - Obesity

• Registration Number: ACTRN12619001045101
• Lead Sponsor: The University of Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-24
• Study Completion: 2020-06-01
• Last Update Posted: 10 August 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

i) meet the American College of Rheumatology clinical and radiological criteria for hip osteoarthritis including:
a) aged between 50 and 80 years old
b) pain in the groin or hip region on most days of the past month
c) joint space narrowing and femoral or acetabular osteophytes on x-ray;
ii) report history of hip or groin pain for longer than 3 months;
iii) report a minimum hip/groin pain score of 4 on an 11-point numeric rating scale during walking over the previous week;
iv) have a body mass index (BMI) between 28 kg/m2 and 41 kg/m2;
iii) report a stable weight (less than a 2 kg change over the previous 3 months);
v) able to give informed consent and to participate fully in the intervention and assessment procedures;
vi) willing/able to use the internet for video consultations with the dietitian and physiotherapist; and
vii) have ability to weigh themselves

Exclusion Criteria

:i) inability to speak English;
ii) on waiting list for or planning spinal/lower limb surgery in next 12 months;
iii) previous arthroplasty on affected hip;
iv) recent hip surgery (past 6 months);
v) self-reported inflammatory arthritis (e.g. rheumatoid arthritis);
vi) any neurological condition affecting lower limbs; viii) inability to safely participate in moderate-intensity exercise as determined by the Exercise and Sports Science Australia pre-exercise screening form.
vii) unable to undertake very low calorie/ketogenic diet for medical reasons including self-reported:
a) diagnosis of Type 1 diabetes;
b) Type 2 diabetes requiring insulin or other medication apart from metformin;
c) warfarin use;
d) stroke or cardiac event in previous 6 months;
e) unstable cardiovascular condition;
f) fluid intake restriction;
g) renal (kidney) problems (an eGFR of <30 mL/min/1.73m2);

Study & Design

• Study Type: Interventional
• Study Design: Not specified